Transtornos de personalidade

Referências

Principais artigos

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington, VA: American Psychiatric Association; 2013.

Hahn SR, Thompson KS, Wills TA, et al. The difficult doctor-patient relationship: somatization, personality and psychopathology. J Clin Epidemiol. 1994 Jun;47(6):647-57. Resumo

Devens M. Personality disorders. Prim Care. 2007 Sep;34(3):623-40. Resumo

Paris J. Clinical trials of treatment for personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):517-26. Resumo

Cristea IA, Gentili C, Cotet CD, et al. Efficacy of Psychotherapies for Borderline Personality Disorder: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2017 Apr 1;74(4):319-328.Texto completo  Resumo

Storebø OJ, Stoffers-Winterling JM, Völlm BA, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5:CD012955.Texto completo  Resumo

Abbass AA, Kisely SR, Town JM, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2014 Jul 1;(7):CD004687.Texto completo  Resumo

Herpertz SC, Zanarini M, Schulz CS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry. 2007;8(4):212-44.Texto completo  Resumo

Gunderson JG, Stout RL, McGlashan TH, et al. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry. 2011 Aug;68(8):827-37.Texto completo  Resumo

Artigos de referência

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington, VA: American Psychiatric Association; 2013.

2. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970 Jan;126(7):983-7. Resumo

3. Lenzenweger M. The longitudinal study of personality disorders: history, design considerations, and initial findings. J Pers Dis. 2006 Dec;20(6):645-70. Resumo

4. Bajaj P, Tyrer P. Managing mood disorders and comorbid personality disorders. Curr Opin Psychiatry. 2005 Jan;18(1):27-31. Resumo

5. Gunderson J, Weinberg I, Daversa M, et al. Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder. Am J Psychiatry. 2006 Jul;163(7):1173-8. Resumo

6. Oldham JM, Skodol AE, Kellman HD, et al. Comorbidity of axis I and axis II disorders. Am J Psychiatry. 1995 Apr;152(4):571-8. Resumo

7. World Health Organization. International statistical classification of diseases and related health problems, 10th revision: ICD-10. 2010 [internet publication].Texto completo

8. Samuels J, Eaton WW, Bienvenu OJ 3rd, et al. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry. 2002 Jun;180(6):536-42.Texto completo  Resumo

9. Crawford T, Cohen P, Johnson J, et al. Self-reported personality disorder in the children in the community sample: convergent and prospective validity in late adolescence and adulthood. J Pers Disord. 2005 Feb;19(1):30-52. Resumo

10. Grant B, Hasin D, Stinson F, et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2004 Jul;65(7):948-58. Resumo

11. Trull TJ, Jahng S, Tomko RL, et al. Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord. 2010 Aug;24(4):412-26. Resumo

12. Volkert J, Gablonski TC, Rabung S. Prevalence of personality disorders in the general adult population in Western countries: systematic review and meta-analysis. Br J Psychiatry. 2018 Dec;213(6):709-715.Texto completo  Resumo

13. Lenzenweger MF, Lane MC, Loranger AW, et al. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Sep 15;62(6):553-64.Texto completo  Resumo

14. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001 Jun;58(6):590-6. Resumo

15. Coid J, Yang M, Tyrer P, et al. Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry. 2006 May;188(5):423-31.Texto completo  Resumo

16. McGilloway A, Hall RE, Lee T, et al. A systematic review of personality disorder, race and ethnicity: prevalence, aetiology and treatment. BMC Psychiatry. 2010 May 11;10:33. Resumo

17. Reichborn-Kjennerud T. Genetics of personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):421-40. Resumo

18. Rhee S, Waldman I. Genetic and environmental influences on antisocial behavior: a meta-analysis of twin and adoption studies. Psychol Bull. 2002 May;128(3):490-529. Resumo

19. Torgersen S, Lygren S, Oien PA, et al. A twin study of personality disorders. Compr Psychiatry. 2000 Nov-Dec;41(6):416-25. Resumo

20. Bradley R, Jenei J, Westen D. Etiology of borderline personality disorder: disentangling the contributions of intercorrelated antecedents. J Nerv Ment Dis. 2005 Jan;193(1):24-31. Resumo

21. Coolidge F, Thede L, Jang K. Heritability of personality disorders in childhood: a preliminary investigation. J Pers Disord. 2001 Feb;15(1):33-40. Resumo

22. Reichborn-Kjennerud T, Czajkowski N, Neale MC, et al. Genetic and environmental influences on dimensional representations of DSM-IV cluster C personality disorders: a population-based multivariate twin study. Psychol Med. 2007 May;37(5):645-53. Resumo

23. Reichborn-Kjennerud T, Czajkowski N, Ystrøm E, et al. A longitudinal twin study of borderline and antisocial personality disorder traits in early to middle adulthood. Psychol Med. 2015 Oct;45(14):3121-31. Resumo

24. Kaffman A, Meaney MJ. Neurodevelopmental sequelae of postnatal maternal care in rodents: clinical and research implications of molecular insights. J Child Psychol Psychiatry. 2007 Mar-Apr;48(3-4):224-44. Resumo

25. Martín-Blanco A, Ferrer M, Soler J, et al. The role of hypothalamus-pituitary-adrenal genes and childhood trauma in borderline personality disorder. Eur Arch Psychiatry Clin Neurosci. 2016 Jun;266(4):307-16. Resumo

26. Essex MJ, Klein MH, Cho E, et al. Maternal stress beginning in infancy may sensitize children to later stress exposure: effects on cortisol and behavior. Biol Psychiatry. 2002 Oct 15;52(8):776-84. Resumo

27. Winsper C, Wolke D, Lereya T. Prospective associations between prenatal adversities and borderline personality disorder at 11-12 years. Psychol Med. 2015 Apr;45(5):1025-37. Resumo

28. Johnson JG, Cohen P, Brown J, et al. Childhood maltreatment increases risk for personality disorders during early adulthood. Arch Gen Psychiatry. 1999 Jul;56(7):600-6.Texto completo  Resumo

29. Eikenaes I, Egeland J, Hummelen B, et al. Avoidant personality disorder versus social phobia: the significance of childhood neglect. PLoS One. 2015 Mar 27;10(3):e0122846.Texto completo  Resumo

30. Spatz Widom C, Czaja SJ, Paris J. A prospective investigation of borderline personality disorder in abused and neglected children followed up into adulthood. J Pers Disord. 2009 Oct;23(5):433-46. Resumo

31. Jang K, Dick D, Wolf H, et al. Psychosocial adversity and emotional instability: an application of gene-environment interaction models. Eur J Pers. 2005 Jun;19(4):359-72.Texto completo

32. Brent DA, Melhem N. Familial transmission of suicidal behavior. Psychiatr Clin North Am. 2008 Jun;31(2):157-77.Texto completo  Resumo

33. Mittal VA, Dhruv S, Tessner KD, et al. The relations among putative biorisk markers in schizotypal adolescents: minor physical anomalies, movement abnormalities, and salivary cortisol. Biol Psychiatry. 2007 May 15;61(10):1179-86. Resumo

34. New AS, Goodman M, Tribwasser J, et al. Recent advances in the biological study of personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):441-61,vii. Resumo

35. Johnson PA, Hurley RA, Benkelfat C, et al. Understanding emotion regulation in borderline personality disorder: contributions of neuroimaging. J Neuropsychiatry Clin Neurosci. 2003 Fall;15(4):397-402. Resumo

36. Friedel RO. Dopamine dysfunction in borderline personality disorder: a hypothesis. Neuropsychopharmacol. 2004 Jun;29(6):1029-39. Resumo

37. Herpertz SC, Bertsch K. A new perspective on the pathophysiology of borderline personality disorder: a model of the role of oxytocin. Am J Psychiatry. 2015 Sep 1;172(9):840-51. Resumo

38. Bertsch K, Schmidinger I, Neumann ID, et al. Reduced plasma oxytocin levels in female patients with borderline personality disorder. Horm Behav. 2013 Mar;63(3):424-9. Resumo

39. Kendler K, Czajkowski N, Tambs K, et al. Dimensional representations of DSM-IV Cluster A personality disorders in a population-based sample of Norwegian twins: a multivariate study. Psychol Med. 2006 Nov;36(11):1583-91. Resumo

40. Tienari P, Wynne LC, Läksy K, et al. Genetic boundaries of the schizophrenia spectrum: evidence from the Finnish Adoptive Family Study of Schizophrenia. Am J Psychiatry 2003 Sep;160(9):1587-94. Resumo

41. Johnson JG, Cohen P, Chen H, et al. Parenting behaviors associated with risk for offspring personality disorder during adulthood. Arch Gen Psychiatry. 2006 May;63(5):579-87.Texto completo  Resumo

42. Helgeland MI, Kjelsberg E, Torgersen S. Continuities between emotional and disruptive behavior disorders in adolescence and personality disorders in adulthood. Am J Psychiatry. 2005 Oct;162(10):1941-7. Resumo

43. Ryder AG, Costa PT, Bagby RM. Evaluation of the SCID-II personality disorder traits for DSM-IV: coherence, discrimination, relations with general personality traits, and functional impairment. J Pers Disord. 2007 Dec;21(6):626-37. Resumo

44. McCrae R, Löckenhoff C, Costa P. A step toward DSM-V: cataloguing personality-related problems in living. Eur J Pers. 2005 Jun;19(4):269-86.Texto completo

45. Skodol AE, Bender DS. The future of personality disorders in DSM-V? Am J Psychiatry. 2009 Apr;166(4):388-91. Resumo

46. Widiger TA. Assessment of DSM-5 personality disorder. J Pers Assess. 2015 Sep-Oct;97(5):456-66. Resumo

47. Eisen JL, Coles ME, Shea MT, et al. Clarifying the convergence between obsessive compulsive disorder criteria and obsessive compulsive disorder. J Pers Disord. 2006 Jun;20(3):294-305.Texto completo  Resumo

48. Huppert JD, Strunk DR, Ledley DR, et al. Generalized social anxiety disorder and avoidant personality disorder: structural analysis and treatment outcome. Depress Anxiety. 2008;25(5):441-8. Resumo

49. Hahn SR, Thompson KS, Wills TA, et al. The difficult doctor-patient relationship: somatization, personality and psychopathology. J Clin Epidemiol. 1994 Jun;47(6):647-57. Resumo

50. Rost KM, Akins RN, Brown FW, et al. The comorbidity of DSM-III-R personality disorders in somatization disorder. Gen Hosp Psychiatry. 1992 Sep;14(5):322-6. Resumo

51. Joiner T, Kalafat J, Draper J, et al. Establishing standards for the assessment of suicide risk among callers to the National Suicide Prevention Lifeline. Suicide Life Threat Behav. 2007 Jun;37(3):353-65. Resumo

52. Moran P, Leese M, Lee T, et al. Standardised Assessment of Personality - Abbreviated Scale (SAPAS): preliminary validation of a brief screen for personality disorder. Br J Psychiatry. 2003 Sep;183:228-32. Resumo

53. Hesse M, Moran P. Screening for personality disorder with the Standardised Assessment of Personality - Abbreviated Scale (SAPAS): further evidence of concurrent validity. BMC Psychiatry. 2010 Jan 28;10:10. Resumo

54. Gorwood P, Rouillon F, Even C, et al. Treatment response in major depression: effects of personality dysfunction and prior depression. Br J Psychiatry. 2010 Feb;196(2):139-42. Resumo

55. Morse JQ, Pilkonis PA. Screening for personality disorders. J Pers Disord. 2007 Apr;21(2):179-98. Resumo

56. Walters P, Moran P, Choudhury P, et al. Screening for personality disorder: a comparison of personality disorder assessment by patients and informants. Int J Methods Psychiatr Res. 2004;13(1):34-9. Resumo

57. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994 Dec 14;272(22):1749-56. Resumo

58. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.Texto completo  Resumo

59. Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007 Mar 6;146(5):317-25. Resumo

60. Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7.Texto completo  Resumo

61. Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000 Nov;157(11):1873-5.Texto completo  Resumo

62. LeFevre ML; US Preventive Services Task Force. Screening for suicide risk in adolescents, adults, and older adults in primary care: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 May 20;160(10):719-26.Texto completo  Resumo

63. Whitlock EP, Polen MR, Green CA, et al. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004 Apr 6;140(7):557-68.Texto completo  Resumo

64. Balint M. The doctor, his patient, and the illness. New York, NY: International Universities Press; 1957.

65. Devens M. Personality disorders. Prim Care. 2007 Sep;34(3):623-40. Resumo

66. Zaheer J, Links PS, Liu E. Assessment and emergency management of suicidality in personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):527-43. Resumo

67. Soloff PH, Lynch KG, Kelly TM, et al. Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study. Am J Psychiatry. 2000 Apr;157(4):601-8. Resumo

68. Apter A, Bleich A, King RA, et al. Death without warning? A clinical postmortem study of suicide in 43 Israeli adolescent males. Arch Gen Psychiatry. 1993 Feb;50(2):138-42. Resumo

69. Fenton WS, McGlashan TH, Victor BJ, et al. Symptoms, subtype and suicidality in patients with schizophrenia spectrum disorders. Am J Psychiatry. 1997 Feb;154(2):199-204. Resumo

70. Duggan C, Huband N, Smailagic N, et al. The use of psychological treatments for people with personality disorder: a systematic review of randomized controlled trials. Pers Ment Health. 2007 Nov;1(2):95-125.Texto completo

71. Paris J. Clinical trials of treatment for personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):517-26. Resumo

72. Gunderson JG. Clinical practice. Borderline personality disorder. N Engl J Med. 2011 May 26;364(21):2037-42. Resumo

73. Cristea IA et al Efficacy of Psychotherapies for Borderline Personality Disorder: A Systematic Review and Meta-analysis JAMA Psychiatry. 2017;74(4):319-328.Texto completo

74. Cristea IA, Gentili C, Cotet CD, et al. Efficacy of Psychotherapies for Borderline Personality Disorder: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2017 Apr 1;74(4):319-328.Texto completo  Resumo

75. Storebø OJ, Stoffers-Winterling JM, Völlm BA, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5:CD012955.Texto completo  Resumo

76. Gibbon S, Khalifa NR, Cheung NH, et al. Psychological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2020 Sep 3;9:CD007668.Texto completo  Resumo

77. Armelius BA, Andreassen TH. Cognitive-behavioral treatment for antisocial behavior in youth in residential treatment. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005650.Texto completo  Resumo

78. Simon W. Follow-up psychotherapy outcome of patients with dependent, avoidant and obsessive-compulsive personality disorders: a meta-analytic review. Int J Psychiatry Clin Pract. 2009;13(2):153-65. Resumo

79. Abbass AA, Kisely SR, Town JM, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2014 Jul 1;(7):CD004687.Texto completo  Resumo

80. Dimeff LA, Koerner K, eds. Dialectical behavior therapy in clinical practice. New York, NY: The Guilford Press; 2007.

81. Duggan C, Huband N, Smailagic N, et al. The use of pharmacological treatments for people with personality disorder: a systematic review of randomized controlled trials. Pers Ment Health. 2008 Jul;2(3):119-70.Texto completo

82. Bateman AW, Gunderson J, Mulder R, et al. Treatment of personality disorder. Lancet. 2015 Feb 21;385(9969):735-43. Resumo

83. Zanarini MC, Frankenburg FR, Hennen J, et al. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry. 2004 Nov;161(11):2108-14. Resumo

84. National Institute for Health and Care Excellence. Borderline personality disorder: recognition and management. Jan 2009 [internet publication].Texto completo

85. Goldberg SC, Schulz SC, Schulz PM, et al. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Arch Gen Psychiatry. 1986 Jul;43(7):680-6. Resumo

86. Koenigsberg HW, Reynolds D, Goodman M, et al. Risperidone in the treatment of schizotypal personality disorder. J Clinical Psychiatry. 2003 Jun;64(6):628-34. Resumo

87. Serban G, Siegel S. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am J Psychiatry. 1984 Nov;141(11):1455-8. Resumo

88. Soloff PH, George A, Nathan RS, et al. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo. Arch Gen Psychiatry. 1986 Jul;43(7):691-7. Resumo

89. Markovitz PJ, Calabrese JR, Schulz SC, et al. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry. 1991 Aug;148(8):1064-7. Resumo

90. Jensen HV, Andersen J. An open, noncomparative study of amoxapine in borderline disorders. Acta Psychiatrica Scandinavica. 1989 Jan;79(1):89-93. Resumo

91. Mercer D, Douglass AB, Links PS, et al. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. J Pers Disord. 2009 Apr;23(2):156-74. Resumo

92. Ingenhoven T, Lafay P, Rinne T, et al. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. J Clin Psychiatry. 2010 Jan;71(1):14-25. Resumo

93. Crawford MJ, Sanatinia R, Barrett B, et al. Lamotrigine for people with borderline personality disorder: a RCT. Health Technol Assess. 2018 Apr;22(17):1-68.Texto completo  Resumo

94. Khalifa NR, Gibbon S, Völlm BA, et al. Pharmacological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2020 Sep 3;9:CD007667.Texto completo  Resumo

95. Sheard MH, Marini JL, Bridges CI, et al. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry. 1976 Dec;133(12):1409-13. Resumo

96. Barratt ES, Kent TA, Bryant SG, et al. Controlled trial of phenytoin in impulsive aggression. J Clinical Psychopharmacol. 1991 Dec;11(6):388-9. Resumo

97. National Institute for Health and Care Excellence. Antisocial personality disorder: prevention and management. Mar 2013 [internet publication].Texto completo

98. Loranger AW, Sartorius N, Andreoli A, et al. The International Personality Disorder Examination. The World Health Organization/Alcohol, Drug Abuse, and Mental Health Administration international pilot study of personality disorders. Arch Gen Psychiatry. 1994 Mar;51(3):215-24. Resumo

99. Alden LE, Laposa JM, Taylor CT, et al. Avoidant personality disorder: current status and future directions. J Pers Disord. 2002 Feb;16(1):1-29. Resumo

100. Herpertz SC, Zanarini M, Schulz CS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry. 2007;8(4):212-44.Texto completo  Resumo

101. Van Ameringen MA, Lane RM, WAlker JR, et al. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study. Am J Psychiatry. 2001 Feb;158(2):275-81. Resumo

102. Pande AC, Feltner DE, Jefferson JW, et al. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clinical Psychopharmacol. 2004 Apr;24(2):141-9. Resumo

103. Pande AC, Davidson JR, Jefferson JW, et al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol. 1999 Aug;19(4):341-8. Resumo

104. Soloff PH. Symptom-oriented psychopharmacology for personality disorders. J Psych Prac. 1998 Jan;4(1):3-11.Texto completo

105. Soloff PH. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulse-behavioral dysregulation. Bull Menninger Clin. 1998 Spring;62(2):195-214. Resumo

106. Ripoll LH. Clinical psychopharmacology of borderline personality disorder: an update on the available evidence in light of the Diagnostic and Statistical Manual of Mental Disorders - 5. Curr Opin Psychiatry. 2012 Jan;25(1):52-8. Resumo

107. Bellino S, Bozzatello P, Blandamura A, et al. Antidepressants in the treatment of borderline personality disorder: a review of literature data [in Italian]. J Psychopathol. 2009;15(2):163-76.Texto completo

108. Kleber HD, Weiss RD, Anton RF Jr, et al; Work Group on Substance Use Disorders. Treatment of patients with substance use disorders: second edition. Am J Psychiatry. 2006 Aug;163(8 Suppl):5-82. Resumo

109. Rudd MD, Mandrusiak M, Joiner Jr TE. The case against no-suicide contracts: the commitment to treatment statement as a practice alternative. J Clin Psychol. 2006 Feb;62(2):243-51. Resumo

110. European Medicines Agency. New measures to avoid valproate exposure in pregnancy endorsed. Mar 2018 [internet publication].Texto completo

111. Gibbon S, Duggan C, Stoffers J, et al. Psychological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007668.Texto completo  Resumo

112. Reyes-López J, Ricardo-Garcell J, Armas-Castañeda G, et al. Clinical improvement in patients with borderline personality disorder after treatment with repetitive transcranial magnetic stimulation: preliminary results. Braz J Psychiatry. 2018 Jan-Mar;40(1):97-104.Texto completo  Resumo

113. Schulze L, Grove M, Tamm S, et al. Effects of transcranial direct current stimulation on the cognitive control of negative stimuli in borderline personality disorder. Sci Rep. 2019 Jan 23;9(1):332.Texto completo  Resumo

114. Zanarini MC, Frankenburg FR, Hennen J, et al. Prediction of the 10-year course of borderline personality disorder. Am J Psychiatry. 2006 May;163(5):827-32. Resumo

115. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry. 1999 Oct;156(10):1563-9. Resumo

116. Gunderson JG, Stout RL, McGlashan TH, et al. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry. 2011 Aug;68(8):827-37.Texto completo  Resumo

117. Soloff PH, Fabio A, Kelly TM, et al. High-lethality status in patients with borderline personality disorder. J Pers Disord. 2005 Aug;19(4):386-99. Resumo

118. Oldham JM. Borderline personality disorder and suicidality. Am J Psychiatry. 2006 Jan;163(1):20-6. Resumo

119. McMain S. Effectiveness of psychosocial treatments on suicidality in personality disorders. Can J Psychiatry. 2007 Jun;52(6 Suppl 1):103S-14S. Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal